Stryker Corporation (NYSE:SYK) Analyst Rating Consensus

Stryker Corporation (NYSE:SYK) has received a short term rating of buy from experts at Zacks with a rank of 2. The stock has been rated an average of 1.9 by 24 Brokerage Firm. 14 Wall Street Firms have rated the stock as a strong buys. 2 stock experts have also suggested a buy rating. 6 Brokerage Firms have advised hold. 2 Analysts have rated it as strong sell.

Other Equity analysts have also commented on the company shares. Guggenheim Securities initiates coverage on Stryker Corporation (NYSE:SYK). The current rating of the shares is Buy, according to the research report released by the firm. The rating by the firm was issued on June 9, 2016.

Stryker Corporation (NYSE:SYK): 18 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $117.72 in Stryker Corporation (NYSE:SYK). However, the stock price could fluctuate by $ 10.07 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $134 price target with the lower price estimate is calculated at $88

Stryker Corporation (NYSE:SYK) rose 0.32% or 0.37 points on Tuesday and made its way into the gainers of the day. After trading began at $116.51 the stock was seen hitting $116.92 as a peak level and $115.87 as the lowest level. The stock ended up at $116.46. The daily volume was measured at 1,043,825 shares. The 52-week high of the share price is $116.99 and the 52-week low is $86.68. The company has a market cap of $43,554 million.

Shares of Stryker Corporation rose by 0.9% in the last five trading days and 5.63% for the last 4 weeks. Stryker Corporation is up 11.38% in the last 3-month period. Year-to-Date the stock performance stands at 25.76%.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.